TRHC - Earnings call transcript Q2 2020 | Tabula Rasa HealthCare, Inc.

Due to licensing restrictions, you must log in to view earnings call transcripts.

Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Q2 2020 Tabula Rasa HealthCare, Inc. Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded. I would now like to hand the conference to your speaker today, Kevin Dill, General Counsel. Please go ahead, sir.

Kevin Dill

morning. good and you, Thank I'm Kevin Rasa of Corporate Counsel Tabula HealthCare. Dill, of intends Litigation harbor XXXX. to company the Reform avail of Securities The Private itself safe the provisions Act of within call be this law. during made of that statements forward-looking Certain statements the meaning will subject actual These HealthCare's by and other Tabula to the or implied differ materially forward-looking risks, factors forward-looking to uncertainties could that statements cause expressed statements. are results Rasa from those and technology-enabled services include uncertainties developing of health the laws care for regulations our products potential These may risks and and and the nature to changes impact market that clients.

risks For and this additional Risk information Tabula XX call it a link is on website, March Investor please on with for days. filed including XX-K the refer filings to accessible page the through the X, our SEC, of the our facing our will on XXXX. of HealthCare, recording Relations available of section be Factors Rasa A

call Rasa I'll over Tabula of to the Knowlton, and Founder Calvin Dr. HealthCare. Now turn CEO, Cal? Chairman

Calvin Knowlton

Kevin Kevin. Orsula our to Greetings conclude Dr. our Sales call. are and today thank us our Marketing Officer; New Officer; With me Business XXXX for for second Chief and Development quarter joining Officer. Co-Founder, remarks. Adams, earnings with you, prepared respond our Chief Knowlton, be Thank you Dr. Boesen, Orsula Kevin Brian Mr. to Financial questions we and will us Chief and after

by website, remarks. available follow a to to As a and our the you presentation reminder, encourage of call with prepared this would download PowerPoint conference along accompanied the is I IR webcast at and section our slides

PACE; we quarter early I'm areas pandemic, reflected Medicaid. revenue non-GAAP guidance MedWise Given X. range. $XX.X XXXX the million on X EBITDA million, focus key pleased which to the last ongoing pronounced PrescribeWellness; COVID-XX MedWise first, by X on second areas: our my are bookings; These both $X.X since May, then, of and to want posed managed total adjusted comments then, I and of report then, and became within in are reported and challenges more Slide

another forced slowed that we a number in year-over-year and In MedWise delivery a exponentially to sequential health to strong their our in XX% materially late we decline within to year said, compared that PACE basis With experienced CareVention response ago plans, expectations could sales on in operations Unfortunately, with the census of segment, our opportunities XXXX. current business change had our sales do been activity. organizations specifically, bookings sales as due we exiting First, a have strong resulting first to and stages has in which quarter to QX. processes, pandemic, along which a large increased increased their as a HealthCare segment have alter our of compared care COVID-XX, HealthCare quarter. of softness to

with PACE, on Second, the I disproportionate population data as than of which, largely beneficiaries. in you In Medicaid July, rate updated wanted than higher COVID to provide of at community-based another on more dual-eligible many PACE, virus XX, X.Xx and is the has update published beneficiaries. on we late Medicare individuals CMS dual-eligible the vulnerable comprised know, impact had serve hospitalized showing a Medicare-only

number existing data to growth trended million X%. greater than growth, mid-April snapshot July, in Our the from COVID-XX members number prior on and by of than usually shows throughout in CMS more CMS totals X.X cases, June. PACE of a in Medicare the from June. peaked peaked and of May in Similarly, where has hospitalizations late XX% data down enrollment The steadily it most early trended sharply the ensuring the COVID recent safety X.X% of was down patient positive clients are its Americans, the staff. focusing side, which and has On shows

enjoyed Our CareKinesis the at the the overall we shows internal to market materially pandemic have than continue we and faced. faster rates but not data given for challenges clients historically our our clients grow short-term

our in March. number was census negative a from shared deaths. a driven And April spike material deaths. showed driven our turning During first company decline census in number the of in to of and entirely versus July a May, our QX in encouraging, positive for by trends data back in with we reversal The time is June by the call, census that month, growth history, each the

by above centers continue see existing few and We members on figures, geographic centers offset a hotspots. to PACE new pre-COVID or opening new levels par adding at

to PACE new or client We year-end. and now have expansion open a sites, scheduled XX between PACE programs

the scheduled In by an integrated PACE, preferred have and already addition, we programs program the on the XXXX. pandemic expansion highlighted attributes in value-based the to new sites Last PACE designed setting. of care positive supported home as or despite has within short-term care open this the a team headwinds, dozen coordinated

PACE-at-home have this with PACE construct our of adopted Some organizations success.

as the to real new Third, I'm community MedWise new efficient amongst visually a excited or tremendously an helps sandbox. quantitatively July pharmacists to regimens enables score sandbox includes to accumulative pharmacy patient's about feature simultaneous will of complex MedWise assess the that results. medication support decision on manner interactions medication a the our medication time. the in within multidrug the medication known which medication This regimen new and The risk launch impact to in simulate network, support see PrescribeWellness changes score talk decision feature

includes I a MedWise pharmacy wanted the with of share to even are closed within Fourth, pharmacists. network, from pipeline Now offering reach regarding of thousands the one sales data that community PrescribeWellness first positive some to hundreds MedWise opportunities and recent this potential we week large of and the pharmacy several our have building community wins.

in that plan, completed targeted clinical high-risk managed inhibition well medication medication hundreds associated risk show risk opioid in Medicaid higher above targeted a is those large of scores designed to discontinuing risk the time addressing program included a MedWise administration with interventions safety as XX. XX.X% the other were and the patients having scores. reviews dosing population. client the when We X.XX therapy reduce regimen, the or total competitive factors of or change group benefit. and medication this a risk For and medication to medications than with of average XX. an as on therapy deprescribing for we a care units patients In able we MedWise This represented reduction Common of recommendations change summary, the above scores score of for

by units. of the able risk were analyzed, we or declension was of MedWise the average to X.XX XX risk more patients for the we MedWise XX% score score, While the reduce

are utilization no lagging patient and reduction annual year. are we $X,XXX, the to false PACE, medical unit In the prescribers whenever X in in one taking The In touch recommendations. of capitated financial is believe our the score. this medications. per The XX% acceptance reduction retrospective the at the touched hospitalizations and EMTM every EMTM percent, has us to the patient EMTM for we after in our medical $XXX quarters. in a peg is patients and PACE, Since Why? in each Now is the before project, We medication reduction accept mimic intervene to month the only spending medication monitor are at environment whom dispensed. a the unit expense. prospective equates visits will respectively, altered. there prescribers And less our regimen threshold interventions in $XXX in indicator, we interventions from least the the ER and at in somewhat next risk full been are and with will over few risk financial are risk

Our overarching that all MedWise certified goal as enroll as pharmacists more interventions will we and be community pharmacists. more Advisor MedWise is prospective,

that was that of value about we the XX.X to talk found positively now addition Brian? to population, impact a Medicaid key financials. our MedWise can younger participants I program for years. our it us in turn This So program it the age important this it population. establishing for is over Brian will was to in average demonstrates

Brian Adams

Thanks, Cal.

XXXX, in quarter our anticipate and want for segment. marked dive Before previously into revenue the everyone to second the for profitability comparison a same revenue results. remind increased with as well segment compared I XX%, quarter MedWise I CareVention reasons that XXXX not as did MedWise we X. decreased and numbers, ago. a MedWise as to factors overall the difficult influence Starting both of a of the it for discussed, record year those second Slide we've XX% period our to making And revenue

a revenue million quarter. a flat year ago of to As result, compared basis a higher the first million as $XX.X X% sequential and on total as to compared was $XX.X

of quarter, had XX%. segment, comprehensive declined Within On interventions the subscriptions services the up services originally increased XX%, first medication reviews forecasted. safety as MedWise compared a but we to total medication XX%, with and increased number significantly by sequential clinical basis, safety medication as software the

profitability, revenue continue have shared expect COVID-XX growth we While and evidenced corporate drive services. to we our a need impact to to XX% to growth, temporary by as future in invest on

as Additionally, down we these X to Non-GAAP $X.XX corporate of a $X.XX $X.X shared margin. million margin; increased and our result of MedWise from And EPS lower a diluted anticipated ago. segment non-GAAP year. a profitability last of EBITDA compared factors, within adjusted adjusted year segment, a million, excluding adjusted million, decreased XX% XX% By X% ago. to $XX.X an $XX.X from to year services, down is MedWise CareVention million $X.X XX% EBITDA is

X. Slide to Moving

million, the $X be in $XX EBITDA to range midpoint of to be $X a which modestly growth represents the the QX. QX in $XX basis expect HealthCare compared CareVention expect be We to to of and Furthermore, million revenue revenue to year flat higher million. to sequential on range versus we to a million total non-GAAP adjusted ago; X% of

flat starting basis versus XXXX. be HealthCare and major QX We modestly originally the signing to sequential expect delayed revenue until versus expected, QX as our on being a largest QX, X contract wins with to QX, lower in MedWise

to on X. Moving Slide

growth to project basis. $XX cases, range key million. of delays trade all we or shifting census to is pharmacy midpoint for now full to revenue some impacting are: COVID-related PrescribeWellness. deals $XXX COVID-related two, total a implementation shows year-over-year of noted importance, which expect in progressing the our and in PACE cancellation the million, million opportunities through current midpoint largest year-to-date lines, the $XX the slowing by in one, key substantially time XXXX, $XXX impacting sequential and we growth; the XXXX, up the in release, to In of respect million with closing the we've point, prior range, in previously using respect With down negatively X% press health XX% this in million. year see and the reduction pipeline, four, order to our to $XX three, factors revenue of our market EBITDA health adjusted season For in coming with plan QX; the as range be end delays represents to of in continued QX on the strong in plans, non-GAAP a late-stage to first and sales selling XXXX; funnel and our we major experienced deals of cited growth With sales be of

as on XXXX, adherence relaxing delivery. home well limits closing would we to as from and including We in waiving attribute medical ratios restrictions the low of However, of at benefiting the wake contracts. half the potential unusually taken health about second utilization CMS and strength actions seen mail prescription this the loss in in by rates have refill pandemic, and in uncertainty delays the a recovery improved plans and

in business that to investing in reduction Lastly, disproportionately the view is our continue our effectively our areas future to by given of on all outlook on execute growth XXXX, order plans. the revenue, EBITDA it across is important impacted

X. to Turning Slide

XXXX earnings in our not time, see While until QX towards we a guidance organic point call, as will this our rates. formal historical path of to we growth returning provide

early outlook Given details fourth our be thought the census HealthCare. trajectory some during If revenue with our for return rates important would half to CareVention continues, pre-COVID second XXXX, our XXXX. to of enrollment Starting growth to PACE optimism for modest we it would recent provide quarter. we the behind expect

slated are our of QX. the vast and emphasis majority on second the for with existing expansions addition, PACE of half starts In XXXX greater with a clients new

have and starts a also for We dozen expansions already new scheduled XXXX.

$XX deal cited annual thousand a late-stage earlier to Shifting and the Lastly, of PACE represent few in excess MedWise. in lives revenue. million well

for during in first have As the plan potential evidenced the XXXX, place ongoing. with strong health of we comments, revenue that active discussions agreements higher half expansion cycles results expect sales service outcomes, and master plans. With by exponentially conversion nation's higher in delivered with health deliver we rates Cal's proven some and to largest shorter accounts earlier the of XXXX have new

has quarter gap software rate XXXX last current order announced XXXX. entering revenue short, our is long-term to win potential growth in pharmacy In in key to close the growth XXXX to to our as smaller significantly our addition, to in In return our target drive compared double-digit subscription.

at the for first With profitability reap that, as the Lastly, rate his a to revenue, back benefits we turn spend investment XXXX is expected our XXXX to closing and of faster heavy grow half Knowlton will materially I Cal? in Dr. XXXX. it of comments. than over

Calvin Knowlton

let's impact in in XXXX Operator, Early as the having late for late-stage centers evidence census Q&A. of have second to Thanks, success deals, in number growth again while I growth the open all of prospects XXXX by which XXXX and with summary, mentioned, will our open PACE large Brian. contracted Brian by meaningful increased am for encouraged QX sales. a as And The QX, MedWise way. trending that well been the PACE call that in is the of impacted positively. half we're COVID-XX,

Operator

first [Operator Dodge comes question RBC Capital Instructions] of Our Sean from Markets.

is Your line open.

ThomasKelliher

This good Sean. for morning. Thomas question. Kelliher Hey, Thanks is taking on for the

I've one So on got pipeline. sales

mentioned the bit but about this through of mechanics growth? the It's involved sales grow. about about in normalizing talked in we growth XXXX, relative up revenue continuing little You now XX% to Then increase XX-ish year-over-year. pipeline kind that? potentially walk to you rates you a percent think Can significant us calculating for how should it's

BrianAdams

into the the for Brian. return I after part, I have ask then Maybe a - call. - Kevin to this maybe can is and get normalized rate joining answer Why to growth and the Thanks, don't that. Tom, first

KevinBoesen

question, business across units, the call to growth the and respect Thomas, for payer the morning. for pharmacy this the we PACE, pipeline, thanks for Yes. at thanks everybody joining space. With in the aggregate different look

those aggregate, strong. pipelines in are So all

payer space is we And and One to we technology obviously, had what science has record programs. seen in growth bookings other most the MedWise the year, compared of our from in the quarter. payer have focus, to other any our been QX extend to significant any

the And sequentially So that about in growth then, health we year-over-year had plan increase. six-fold exponential about quarter-over-quarter was mentioned, a XX% as Cal bookings.

stage In other late relative are sort things the of terms that and tracking bookings pipeline. within to the of movement we're that

a had leads in we're we've increase really qualified quarter-over-quarter, late-stage So XX% tracking. what terms those in of proposals,

having pandemic had at moving from to And moved so from those level a confidence reasons, this pre of sort XXXX be look those our are what's be delay how we to contracts to and been we anticipated of what XXXX.

Brian Adams

midpoint little to as And at in maybe XXXX, just talk level about a this the setting bit about our sequentially look as million. And our year, growth tracked steadily past the now confidence our $XXX at guidance of we increased we're you we've on has basis, from and call. a that earnings months, that quarter census point at low saw few PACE over and first it that monthly

excess then Health $XX deal signed get we've the $XX growth will some that by was that next to end year be have seen a couple his another $X out And We've PACE as - from where the impact in deals ourselves million position payer with deals for enrollment contribute rates. in the pharmacy year contribution from PACE And pushed our and we that a so should million. of that we're the that hopefully, to are should million. PACE back about result, million have million about just confidence Kevin got customers, $X within organic that team and that existing we're that the another Mart late-stage of pre-COVID $XX

you just that a need for million those to the growth in XX% rate. puts combine we to very to of all it together, you get growth when $XX would So things close

this half where online in centers and going lot that slightly positive comp point I that time come to were from I next year, we're while a we back into And going were position latter the say year think year But to just move challenging, it I this So are year. next sit does year is help a ago. be where think PACE this look when XX to versus that of much than we got of better a we I'll today, as especially we factors perspective between last year. very next a at in we've got we've now

Thomas Kelliher

very That's one. then And quick helpful. just another

in more little You're Or growth QX. bit majority that? ramping a returning kind all driving of much that in pretty dependent that to embedded What's on of reviews? what's the Is assumption? medication

Brian Adams

Sure.

PACE X over bit expecting are a bit growth do latter a reviews next are half the So expecting we ramp that of the little quarters. have little of to this over but year, clinical we we

So and closing, working on have little on some QX of impactful will been meaningfully team more bit in and a be that those then Kevin the QX. deals his and

Operator

next Ryan Blair. comes William of Daniels Our from question

open. is line Your

JaredHaase

morning. all is on maybe for margin the Brian, Ryan. for Good Yes. sort in Jared This Haase Thanks the dynamics. questions. of just gross one

the seeing like, and of a the talk Can QX MedWise it outlook that maybe thoughts for the So faster sequential of in about there year? the services QX? little in about Should in Just the XXXX. that for sounds improvement on decline just obviously, of kind bit some think improvement pressured rest you dynamic revenue. sequential we then by was the rest any

Brian Adams

Yes.

in about seasonality, to that the it, that's way right of terms think I think Jared.

pressured or flat, an given of you and as So for QX you've But as the the a MedWise to the that QX year, fact compared slight improvement going got QX. year - segment. into it's were then was quarter QX some extremely strong to strong probably from last know, level going and margins XXXX

you QX then but year, see comp QX. a will a to it was into this going So and little of bit challenging for improvement

Jared Haase

then allocation Yes, capital on it. priorities. just And Got super that's helpful.

of on slowdown short-term R&D, maybe and product thoughts you just maybe you could there. in? the development, any you to invest investment sales of lot infrastructure, to guess, and continue in, hear want on of invest XXXX that comment through any to support target set focused of maybe specific marketing of that to up. Any XXXX the some to in dynamics a areas whether good that's that it's continuing comments specific platform to you're So looking you're support kind growth in kind for looking positive that I areas the to more

Brian Adams

Yes.

marketing. and with and important manage IT in invest way. But of algorithms terms in that business. continuing that's science to a harmonizing the think are continue we investing we R&D, are future Similarly, to a in the we're of In using risk that the the pretty we longer-term the in spend, that, side. time, to we sales on have invest growth We novel same medication the lot platforms of at for

unification So with core and necessarily platforms investment platform, but going the there of there a Tabula some ultimately Sinfonía is we today. PrescribeWellness, have, a Rasa managing business, in number so not on specific that that we're of one

to some should outer So point million generate the right But for of balance available the have, $XX to there our be capital projecting now, We're in about in sheet, we between the we've about that on terms $X on million $XX savings $X and years of million got year. of this cash this that. somewhere credit. related at line

open the capital in sense M&A and we if to not that the does you've seen Rasa growth. business has of our part assets to see to or continue access order the And activity I So are market, will the there make say to - to eyes in as Tabula future keep become family. increased, the might companies that need fund additional

positive capital eyes very deployed could think, our keep to the and I there open have, continuing we're be manner. that a in So

Operator

Securities. comes Draper Sandy Truist Our next question from of

line is open. Your

Unidentified Analyst

for Hi. Thanks. Sandy. on is This [Stan]

changes of any in the can quarter, when duration on comment contract bookings at First, deals average you the maybe looking in value? or the notable

KevinBoesen

of reaching some trying get more is of I'll success lot the are jump specifically base. to goal the if science on into MedWise the look Yes. great driven in. a plan our We've of side, the which national we in had bookings payer health where

and did grow and we of to multimillion-dollar a those opioids, with inhibition, So Humana. those typically us the - do looking grow be national will smaller scores the the similar programs. seen million at Medicaid And it work from impact to space, the in competitive what looking with what a initially contract those, lot trying we program health of the patients get that of with we've a that And in payer with range lot to start on launched initially - helps and program really plans a at, we've that may large integrate then science $X.X high-risk to contract.

start add-on pharmacy on to interventions that So some but with the our Stars the also different and measures. science, HEDIS not it's targeting typical improving network, journeys some we of related services, bundling of it community programs, then client only we some with to continue really MedWise and through PrescribeWellness pieces

only deals, in larger the of closing deal So terms not a with but larger lot of are we sizes. growing pipeline, companies, those they're and and those are

plans However, say you want start-up as version that interested the well at in new through in looking are necessarily benefits. to to Medicare of pharmacy I mix really it's several costs how don't there that that manage more because limited medical all are

both. was within of X wins their the of national so MedWise driving integrated with science But X programs, us. a of And huge mix of in it payer for the the goals terms exposure of there's one big really

Unidentified Analyst

question then And maybe Helpful. Brian. a it. Got for

year? on at recognition considering expenses? that in accelerate year, in operating levers leverage, touched are about think we growth revenue looking should Just But of be you know thinking we the and sales recognition operating and the leverage investing think I next operating you should you next of how marketing as of about XXXX, when about cadence guys where R&D. the

Brian Adams

Sure.

see year, a this our you're going that revenue. into at not continued as modest investment but I certainly that you're year, of next be will percentage it So rates overall seeing going some think to the

stay will the I of on G&A continue similarly, think but a those at that So I to side, revenue. to look and of And not absolute you percentage then dollars, marketing, would increase the going terms as buckets, expect next X as X year. into pretty R&D steady and in sales

Operator

question comes of Piper Sean Our Sandler. Wieland next from

is line Your open.

JessicaTassan

Hi. for Good Sean. morning. It's Jess on

maybe elaborate was how the side? the it MedWise the And changes just if did your on if ratings at fulfillment interested Star on quarter? impacted you guys medication safety services in then contracts, changes influence more Ratings Or just Just that the all? could

Brian Adams

Jess, material Star changes give So if influenced And the think in that, that be XXXX. the really maybe background would some could you Ratings helpful. I on Kevin, maybe,

Kevin Boesen

Sure.

terms a Star In lot - of some is the Ratings side that service our of drive of the revenue review on MedWise rates. the med comprehensive

rates review as CMS the years, comprehensive meaning an med for so target And health if to has percentage the MTM aggressively they patients over that qualify the have increased they a program. for plans, of want

so a growth. have - drove saw Medicare really Advantage Those that of in XXXX, the a lot up range. in plans, to we the increase large that rates for And XXXX, gone XX%

in a And driver for so increase have services. to continued be there's movement lot that not a continued of

interest want growth percentage connected a The Advantage starting having in they really sort plan And who Star that's from reviews. driving having that in the plans, types the MedWise. Medicare that's opportunity the med key of comprehensive of those a we looking to services and health of And then see rates. really impact in opened of comprehensive shift that, the door change with a review, because the for the it's shift we're the reviews, are at really it's what is so Ratings those of that's patients med additional the some impact really as

of that our do that's be competitors we pipeline so of care, that's a that the us plans the - as plans of as the piece as reducing valuable services some within to terms Tabula technology, that overall those been key do about growth we year of trying science, talk or So And being more have in can't have where able opportunity in-house own. to data. driving to cost total to so our think producing I core Rasa in offer and their another we're to service something on

that's as that the in the mentioned, quantifying really published, that study us. we're in seeing We really also that. that's with quarter savings specifically. really Cal looked a Ratings shift But the second And helped associated dollar Star at

Jessica Tassan

ask or I one XXXX you contract? MedWise a that that can just components XXXX likely some risk-based or on And it. event of more those Got then? savings-based incorporate that of the Is

Kevin Boesen

of - is pipeline majority - XXXX in half so the of XXXX. the It's the first launch, been has

had been as and a as revenues gave of mentioned, of bookings clients some the within is that of expecting I those of second we've terms from Brian of that well. implemented XXXX we're that XXXX the the around some couple Although, got in what XXXX. XXXX But majority pushed review from half that that's to

Operator

Our next question SVB of comes from Leerink. Stephanie Davis

Your line is open.

YueliZhang

on start This on perhaps Zhang is Joy give you contract for to on CVS Stephanie. guys. Hey, update I can an delay? guess us the off, the and some details what drove

Kevin Boesen

and discussions CVS with in appreciate still that. is I jump a standpoint, talk in year will about about the what Kevin. second - This them this From can can of I Joy. like. the look Yes. question, half we're

supply. in we terms in a key year up, relative driver of at of for year Probably modest unexpected, only last upon number years, driver or to to looking because adherent pharmacies year is day dependent specifically largely compared this at prior the a community need a sales, allow of this more that medication time been the to they we've of anticipate sort key compared put that some the Patients our some points brought initiatives were to that this adherence, more lot and year are at with CMS for. the of support made changes So overall sit of Star second we if which forecasting. this early half of you has look which Ratings, clinical patients what where for

help medications. during just patients pandemic, the And allowed to medications yet. seen manage to we So haven't patients' that catch-up were access excess

some we the sort And provide in relative of the [Indiscernible] so delays will year. services the that of second half caused of that has to

Yueli Zhang

the you. confidence guess, 'XX, Got was second - to I that ramp now that and the out going next pushed it's in pushed guess, pushed to with originally mind, year? I you what out to the FY gives since half contract

Kevin Boesen

on clients in any - based that we that experience think haven't programs have, in We the that. discussions of changes have and terms with necessarily seen that we the we

we're isn't services. the of the pharmacy that some at they us to - is types services and want in the with space, challenged try really dealing there, PACE anything for service, have look terms And relative those X several and been vision we are. of you that supporting the where there has meet have The I with are day-to-day, mean, in pandemic. immediate adding care - they're relative stalled And to the medication to just of really the needs in conversations it space. markets been of So the of the sort frontline that as services. having markets with clinical to are those for patient they months sort in managing we're the of provide, workers all challenge who provide we fulfillment

getting of the in And second of the track see started tail so bigger terms coming in conversations quarter, terms sort change those as what's end at picture. of back really to in on we're of July the we

pandemic the lines. how saw sharp in I business they standpoint, a just that that being think delay just particular, were really really, about so future, the halt And from with front on it line, thinking a is managing we in really is just the and

Operator

There are participating. gentlemen, today's concludes call. Thank you for no and this further questions. conference Ladies

Everyone, disconnect. great may a day. now You have

Tabula Rasa HealthCare (TRHC) 9 Aug 202020 Q2 Earnings call transcript